Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Quick Stats
Jan 30, 202645.4
AI Score
HOLD0.83
Volume Ratio
Mar 04, 2026
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
OCGN Stock Summary
Last updated Jan 30, 2026
OCGN is currently trading at $1.45, positioned above its 200-day moving average of $1.19, indicating a long-term uptrend. The stock has a 52-week range of $0.515 to $1.96.
Technical Analysis: The 50-day moving average stands at $1.41, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 45.042, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.048, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates OCGN at 45.4/100 with a HOLD recommendation.
OCGN (Ocugen, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 45.042 |
| CMF (20) | -0.048 |
| ROC (10) | -10.494 |
| ADX (14) | 21.546 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.023 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -100.0 |
| MFI (14) | 53.613 |
OCGN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
OCGN Price vs Max Options Open Interest
OCGN Max Change In Options Open Interest
OCGN Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OCGN Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OCGN Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OCGN Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Ocugen, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
OCGN Moving Averages Analysis
Ocugen, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Ocugen, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
OCGN (Ocugen, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.58 |
| 20 | 1.6 |
| 30 | 1.54 |
| 50 | 1.41 |
| 100 | 1.45 |
| 200 | 1.19 |
OCGN Fundamental Analysis
| P/E (Forward) | 15.2207 |
| P/E (Trailing) | -- |
| Market Cap ($) | 504.1 million |
| Earnings/Share ($) | -0.22 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.2275 |
| EPS Estimate Next Year ($) | -0.2375 |
| WallStreet Target Price ($) | 9 |
| Most Recent Quarter |
Investors in $OCGN are feeling bullish as they anticipate a potential breakthrough, with RTW Investments showing confidence in the company by funding an offering. The stock price is climbing higher, with hopes of surpassing $1.69 and potentially reaching $16.90 or even $169 in the long term. This year could see a 10x increase in value, with optimism for continued growth in the coming years.
Updated 2026-01-22 19:00:02